Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia Proceeding/Conference:Clinical Lymphoma Myeloma and Leukemia | 2022 | |||
2021 | 27 | |||
2022 | 1 |